Title of the panel discussion:
Strengthening Europe’s Biotech Competitiveness Through Collaboration Across the Life Science Ecosystems
Panel discussion summary
As Europe develops new policy instruments such as the upcoming EU Biotech Act, strengthening the competitiveness of its life science sector requires closer collaboration across the entire ecosystem - from established pharma and biotech hubs to emerging innovation regions. This panel will explore how different parts of Europe’s life science landscape contribute to innovation capacity through talent, data, research and industrial capabilities. The discussion will focus on how stronger cross-regional and cross-sector collaboration can enhance Europe’s global position in biotechnology.
Date, time and room information
Tuesday, May 5, 12:15 - 13:00, room Osaka/Samarkand
Moderation
| Name | Position | Institution |
|---|---|---|
| Agnė Vaitkevičienė | Vice-president | LithuaniaBIO |
Panelists
| Name | Position | Institution |
|---|---|---|
| Sujoy Chowdhury | Senior Director Clinical Innovation & Operational Excellence (International Operations) | Novo Nordisk |
| Ernst Nagel | Operations Director | Health Holland |
| Delphine Costa | CEO | The Life Science Cluster |
Global Village program
This panel discussion is part of the Global Village program
